HopeStage
Back to all studies
TerminatedNCT03242772

Impact of Combined Medication and Behavioral Treatment for ASD & ADHD

Medication studyAges 36–131 monthsUnited States
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 36 months to 131 months. Other eligibility criteria apply.

Listed locations
DurhamSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 14, 2018
Recruitment status
Terminated
Enrollment listed in the registry
18
Sponsor
Duke University
Sponsor type
University
Study type
Drug
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 36 Months to 131 Months
Official registry ID
NCT03242772
Official title
Show the full official title

Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD

Recruitment & locations

Terminated

Durham

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Duke University, a university.

Does this study involve medication?

Yes. The study involves medication, including Amphetamine and Placebo Oral Tablet.

Who can participate?

This study is for people with ADHD. Listed age limits: 36 months to 131 months. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies